The relationship between the cIMT with traditional cardiovascular risk factors (age, sex, blood lipid levels, blood pressure) as well as with immunoinflammatory markers of cardiovascular risk (sCD40L, sVCAM-1) in patients with RA has been demonstrated. This evidence concerns the gene CD40LG and rheumatoid arthritis.